In Logsdon’s dataset [14], the transcription levels of SMARCA4 were significantly higher in patients with pancreatic adenocarcinoma, with a fold change of 2.257 and a P value of 7.16E−4. This evidence concerns the gene SMARCA4 and pancreatic adenocarcinoma.